MX2014010143A - Terapia de reemplazo para caries dentales. - Google Patents

Terapia de reemplazo para caries dentales.

Info

Publication number
MX2014010143A
MX2014010143A MX2014010143A MX2014010143A MX2014010143A MX 2014010143 A MX2014010143 A MX 2014010143A MX 2014010143 A MX2014010143 A MX 2014010143A MX 2014010143 A MX2014010143 A MX 2014010143A MX 2014010143 A MX2014010143 A MX 2014010143A
Authority
MX
Mexico
Prior art keywords
dental caries
host
mutans
replacement therapy
strains
Prior art date
Application number
MX2014010143A
Other languages
English (en)
Other versions
MX358060B (es
Inventor
Jeffrey D Hillman
James Leif Smith
Shawanda R Wilson-Stanford
Original Assignee
Oragenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oragenics Inc filed Critical Oragenics Inc
Publication of MX2014010143A publication Critical patent/MX2014010143A/es
Publication of MX358060B publication Critical patent/MX358060B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G4/123—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01001—Alcohol dehydrogenase (1.1.1.1)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)

Abstract

La invención proporciona cepas de Streptococcus mutans recombinante que se pueden usar para mejorar la salud bucal. Una modalidad de la invención proporciona un método para reducir la incidencia o severidad de caries dental en un hospedero susceptible a caries dental, que comprende administrar oralmente al hospedero una cepa de S. mutans recombinante aislada de la invención en una cantidad efectiva para remplazar las cepas hospederas de S. mutans que causan la caries dental en la cavidad bucal del hospedero. La cepa de S. mutans recombinante aislada 10 puede estar contenida en un enjuague bucal, pasta dental, goma de mascar, hilo dental, comprimido masticable, alimento, o bebida.
MX2014010143A 2012-02-27 2013-02-22 Cepa de streptococcus mutans para usarse en terapia de reemplazo para caries dentales. MX358060B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261603693P 2012-02-27 2012-02-27
US201261603661P 2012-02-27 2012-02-27
PCT/US2013/027340 WO2013130351A1 (en) 2012-02-27 2013-02-22 Replacement therapy for dental caries

Publications (2)

Publication Number Publication Date
MX2014010143A true MX2014010143A (es) 2015-04-08
MX358060B MX358060B (es) 2018-08-03

Family

ID=49083172

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014010143A MX358060B (es) 2012-02-27 2013-02-22 Cepa de streptococcus mutans para usarse en terapia de reemplazo para caries dentales.
MX2014010151A MX369443B (es) 2012-02-27 2013-02-22 Variantes del lantibiotico mu1140 y otros lantibioticos con propiedades farmacologicas y caracteristicas estructurales mejoradas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2014010151A MX369443B (es) 2012-02-27 2013-02-22 Variantes del lantibiotico mu1140 y otros lantibioticos con propiedades farmacologicas y caracteristicas estructurales mejoradas.

Country Status (10)

Country Link
US (2) US9260488B2 (es)
EP (3) EP3219325B1 (es)
JP (2) JP6297506B2 (es)
CN (2) CN104302307B (es)
AU (2) AU2013226402B2 (es)
BR (2) BR112014020659A2 (es)
CA (2) CA2865405C (es)
HK (2) HK1205519A1 (es)
MX (2) MX358060B (es)
WO (2) WO2013130351A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3484442A1 (en) * 2016-07-15 2019-05-22 Intrexon Corporation Lantibiotic variants and uses thereof
US10577399B2 (en) 2016-10-28 2020-03-03 The Texas A&M University System Modified lantibiotics and methods of making and using the modified lantibiotics
JPWO2020090045A1 (ja) * 2018-10-31 2021-10-14 株式会社村田製作所 抗グラム陰性菌化合物
CA3128389A1 (en) * 2019-03-08 2020-09-17 Fraunhofer Usa, Inc. Novel antimicrobial lantibiotic peptide and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US5516682A (en) * 1988-07-05 1996-05-14 University Of Maryland Subtilin variant of enhanced stability and activity
GB9423404D0 (en) * 1994-11-19 1995-01-11 Biotech & Biolog Scien Res Production of nisin
US5932469A (en) 1997-06-10 1999-08-03 University Of Florida Antimicrobial polypeptide, nucleic acid, and methods of use
US6964760B2 (en) * 1997-06-10 2005-11-15 University Of Florida Research Foundation Antimicrobial polypeptide, nucleic acid, and methods of use
US20060198793A1 (en) * 1997-06-10 2006-09-07 University Of Florida Research Foundation Antimicrobial polypeptide, nucleic acid, and methods of use
US6251478B1 (en) 1999-12-22 2001-06-26 Balchem Corporation Sensitive substance encapsulation
DK1483366T3 (da) * 2002-02-22 2010-08-09 Blis Technologies Ltd Antimikrobiel sammensætning
US20090215985A1 (en) 2005-08-12 2009-08-27 Oragenics, Inc. Differentially protected orthogonal lanthionine technology
US7521529B2 (en) 2005-08-12 2009-04-21 Oragenics, Inc. Differentially protected orthogonal lanthionine technology
US7576054B2 (en) 2005-10-11 2009-08-18 Biosynexus Incorporated Compositions and methods for treating bacteria
WO2008151434A1 (en) * 2007-06-12 2008-12-18 The University Of British Columbia Small cationic antimicrobial peptides
EP2176284B1 (en) 2007-07-20 2013-09-04 Regents Of The University Of Minnesota Lantibiotics and uses thereof
IE20080365A1 (en) * 2008-05-09 2010-03-16 Univ College Cork Nat Univ Ie Nisin derivatives and the use thereof

Also Published As

Publication number Publication date
BR112014020659A2 (pt) 2017-06-27
HK1205519A1 (en) 2015-12-18
MX358060B (es) 2018-08-03
CA2865405C (en) 2021-11-16
CN104321338A (zh) 2015-01-28
AU2013226402A1 (en) 2014-08-21
MX2014010151A (es) 2015-01-14
US9260488B2 (en) 2016-02-16
WO2013130349A8 (en) 2014-01-09
CN104302307B (zh) 2018-10-26
EP3219325B1 (en) 2019-11-06
EP2833902A1 (en) 2015-02-11
EP2833902A4 (en) 2016-04-06
WO2013130351A1 (en) 2013-09-06
MX369443B (es) 2019-11-08
AU2013226402B2 (en) 2017-05-18
US20150044146A1 (en) 2015-02-12
BR112014020656A2 (pt) 2017-06-27
JP6297506B2 (ja) 2018-03-20
JP6309902B2 (ja) 2018-04-11
WO2013130349A1 (en) 2013-09-06
EP3219325A1 (en) 2017-09-20
JP2015509715A (ja) 2015-04-02
HK1205458A1 (en) 2015-12-18
EP2820036A4 (en) 2016-01-20
AU2013226404B2 (en) 2017-11-30
US20150125503A1 (en) 2015-05-07
AU2013226404A1 (en) 2014-08-21
CN104302307A (zh) 2015-01-21
CA2865395A1 (en) 2013-09-06
JP2015509945A (ja) 2015-04-02
CN104321338B (zh) 2018-10-19
CA2865405A1 (en) 2013-09-06
EP2820036B1 (en) 2018-06-06
EP2820036A1 (en) 2015-01-07
US9963488B2 (en) 2018-05-08

Similar Documents

Publication Publication Date Title
WO2012145611A3 (en) Improved stability of peroxide in oral care compositions
AR052044A1 (es) Composicion para el cuidado bucal y control del sarro que contiene extracto de magnolia
PH12015501260A1 (en) Oral care composition
BR112012022040A2 (pt) ''composição monofásica de tratamento oral, produto de tratamento oral e método para o branqueamento e/ou remineralização dos dentes''.
BRPI0906463A2 (pt) Método para tratar ou reduzir as cáries do esmalte precoce, de proteção contra cáries, para reduzir o tamanho de lesões de esmalte precoces existentes e para aperfeiçoar a saúde sistêmica através da aplicação regular de um produto para o cuidado oral, uso de um aminoácido básico, e, preparação combinada
MX343566B (es) Composiciones y probioticos/prebioticos anticaries.
MY152243A (en) Non-aqueous dentifrice composition with bioacceptable and bioactive glass and method of use and manufacture thereof
MX2012001168A (es) Composiciones para el cuidado bucal que comprenden estaño, potasio y monofluorofosfato.
AR089375A1 (es) Composiciones de cuidado oral que contiene una proteasa alcalina y una segunda enzima
MX341274B (es) Formulaciones de enjuague bucal para ser usadas con un dispositivo de suministro en el cepillo de dientes.
MX2014010143A (es) Terapia de reemplazo para caries dentales.
HK1212907A1 (zh) 用於牙釉質增强和增白的礦物酶複合物、口腔衛生組合物和牙膏
MX2015007879A (es) Composicion para el cuidado oral.
MX353908B (es) Uso de bacteria productora de peroxido de hidrogeno para blanquear dientes.
MX2013006435A (es) Composicion para cuidado oral.
PH12014501135A1 (en) Oral care composition comprising isobutyl magnolol
MX2014015380A (es) Proteccion intraoral.
JP2015509715A5 (es)
UY33309A (es) Composiciones para tratamiento dental que comprenden ácidos lipoteicoicos o partes de los mismos como mono o poliglicerfosfatos
PH12014501136A1 (en) Oral care composition comprising n-butyl magnolol and isobutyl magnolol
MX2015005975A (es) Composiciones para el cuidado bucal.
WO2013034414A3 (de) Spezialzahncreme für elektrische zahnbürsten i
WO2011062435A3 (ko) 불소증류장치 및 이를 이용한 치약 내 일불소인산나트륨 정량방법
WO2013034415A3 (de) Spezialzahncreme für elektrische zahnbürsten ii
MY186889A (en) Oral care composition

Legal Events

Date Code Title Description
FG Grant or registration